Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Shares Outstanding (Diluted Average) (2020 - 2025)

AdaptHealth (AHCO) has 6 years of Shares Outstanding (Diluted Average) data on record, last reported at $135.1 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) changed 0.28% year-over-year to $135.1 million; the TTM value through Dec 2025 reached $135.1 million, changed 0.28%, while the annual FY2025 figure was $135.1 million, 0.28% changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $135.1 million in Q4 2025 per AHCO's latest filing, down from $137.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $139.0 million in Q4 2022 and bottomed at $132.9 million in Q1 2024.
  • Average Shares Outstanding (Diluted Average) over 5 years is $136.0 million, with a median of $135.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 153.46% in 2021, then dropped 3.29% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $133.0 million in 2021, then grew by 4.48% to $139.0 million in 2022, then dropped by 3.29% to $134.4 million in 2023, then grew by 0.83% to $135.5 million in 2024, then fell by 0.28% to $135.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $135.1 million in Q4 2025, $137.2 million in Q3 2025, and $137.1 million in Q2 2025.